LeMaitre Historical Balance Sheet
LMAT Stock | USD 104.00 1.97 1.93% |
Trend analysis of LeMaitre Vascular balance sheet accounts such as Total Current Liabilities of 36.1 M provides information on LeMaitre Vascular's total assets, liabilities, and equity, which is the actual value of LeMaitre Vascular to its prevalent stockholders. By breaking down trends over time using LeMaitre Vascular balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining LeMaitre Vascular latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LeMaitre Vascular is a good buy for the upcoming year.
LeMaitre Vascular Inventory |
|
LeMaitre |
About LeMaitre Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of LeMaitre Vascular at a specified time, usually calculated after every quarter, six months, or one year. LeMaitre Vascular Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of LeMaitre Vascular and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which LeMaitre currently owns. An asset can also be divided into two categories, current and non-current.
LeMaitre Vascular Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of LeMaitre Vascular assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in LeMaitre Vascular books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on LeMaitre Vascular balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of LeMaitre Vascular are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from LeMaitre Vascular's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into LeMaitre Vascular current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.At this time, LeMaitre Vascular's Other Current Assets are comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 225.6 M in 2025, whereas Short Term Debt is likely to drop slightly above 2.3 M in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 16.6M | 19.1M | 22.0M | 23.1M | Total Assets | 310.5M | 346.8M | 398.8M | 418.7M |
LeMaitre Vascular balance sheet Correlations
Click cells to compare fundamentals
LeMaitre Vascular Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LeMaitre Vascular balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 252.8M | 292.8M | 310.5M | 346.8M | 398.8M | 418.7M | |
Short Long Term Debt Total | 54.8M | 15.9M | 16.6M | 19.1M | 22.0M | 23.1M | |
Other Current Liab | 5.3M | 4.9M | 7.4M | 23.3M | 26.8M | 28.1M | |
Total Current Liabilities | 25.1M | 21.8M | 25.3M | 29.9M | 34.4M | 36.1M | |
Total Stockholder Equity | 172.6M | 254.2M | 268.2M | 297.9M | 342.6M | 359.7M | |
Net Debt | 28.0M | 2.1M | (2.5M) | (5.2M) | (6.0M) | (6.2M) | |
Non Current Assets Total | 158.5M | 152.9M | 148.7M | 152.2M | 175.0M | 183.8M | |
Non Currrent Assets Other | 909K | 568K | 991K | 3.7M | 3.4M | 3.5M | |
Common Stock Shares Outstanding | 20.5M | 21.5M | 22.2M | 22.4M | 25.8M | 17.3M | |
Liabilities And Stockholders Equity | 252.8M | 292.8M | 310.5M | 346.8M | 398.8M | 418.7M | |
Other Current Assets | 5.2M | 8.4M | 6.7M | 12.1M | 13.9M | 14.6M | |
Other Stockholder Equity | 103.3M | 169.2M | 176.2M | 186.9M | 214.9M | 225.6M | |
Total Liab | 80.2M | 38.7M | 42.3M | 48.9M | 56.2M | 59.0M | |
Total Current Assets | 94.3M | 139.9M | 161.7M | 194.6M | 223.8M | 235.0M | |
Short Term Debt | 6.4M | 3.7M | 3.8M | 2.5M | 2.8M | 2.3M | |
Cash | 26.8M | 13.9M | 19.1M | 24.3M | 27.9M | 18.3M | |
Cash And Short Term Investments | 27.0M | 70.0M | 82.7M | 105.1M | 120.8M | 126.9M | |
Non Current Liabilities Total | 55.1M | 16.8M | 16.9M | 19.0M | 21.8M | 22.9M | |
Other Liab | 5.4M | 4.8M | 2.8M | 2.2M | 2.6M | 1.8M | |
Property Plant And Equipment Net | 31.1M | 32.1M | 33.5M | 39.8M | 45.7M | 48.0M | |
Current Deferred Revenue | 14.0M | 17.5M | 16.3M | 390K | 448.5K | 426.1K | |
Retained Earnings | 70.6M | 88.1M | 97.8M | 115.4M | 132.7M | 139.4M | |
Accounts Payable | 2.4M | 2.3M | 2.9M | 3.7M | 4.3M | 4.5M | |
Other Assets | 1.3M | 18.4M | 2.1M | 2.7M | 3.1M | 2.3M | |
Net Receivables | 19.6M | 19.6M | 22.0M | 25.1M | 28.8M | 30.3M | |
Good Will | 29.9M | 41.7M | 65.9M | 65.9M | 75.8M | 79.6M | |
Common Stock Total Equity | 217K | 221K | 235K | 237K | 272.6K | 194.7K | |
Short Term Investments | 214K | 56.1M | 63.6M | 80.8M | 92.9M | 97.6M | |
Inventory | 45.1M | 46.1M | 50.3M | 52.3M | 60.2M | 63.2M | |
Property Plant And Equipment Gross | 31.1M | 17.1M | 33.5M | 61.3M | 70.5M | 74.0M | |
Accumulated Other Comprehensive Income | (1.5M) | (3.4M) | (6.0M) | (4.6M) | (4.2M) | (4.0M) | |
Treasury Stock | (11.0M) | (11.6M) | (12.4M) | (13.0M) | (11.7M) | (11.2M) | |
Intangible Assets | 58.9M | 52.7M | 46.5M | 41.7M | 48.0M | 50.4M | |
Common Stock | 221K | 235K | 237K | 239K | 274.9K | 198.1K | |
Property Plant Equipment | 14.9M | 15.0M | 32.1M | 17.9M | 20.6M | 21.6M | |
Net Tangible Assets | 108.2M | 113.7M | 135.5M | 155.7M | 179.1M | 188.0M | |
Retained Earnings Total Equity | 57.0M | 70.6M | 88.1M | 97.8M | 112.4M | 118.1M | |
Capital Surpluse | 105.9M | 114.9M | 181.6M | 189.3M | 217.7M | 111.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.